Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis

Background. Preexposure prophylaxis (PrEP) with emtricitabine plus tenofovir disoproxil fumarate (FTC/TDF) or TDF alone reduces the risk of human immunodeficiency virus (HIV) acquisition. Understanding the risk of antiretroviral resistance selected by PrEP during breakthrough infections is important...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Lehman, Dara A., Baeten, Jared M., McCoy, Connor O., Weis, Julie F., Peterson, Dylan, Mbara, Gerald, Donnell, Deborah, Thomas, Katherine K., Hendrix, Craig W., Marzinke, Mark A., Frenkel, Lisa, Ndase, Patrick, Mugo, Nelly R., Celum, Connie, Overbaugh, Julie, Matsen, Frederick A., Coombs, Robert W., Lingappa, Jairam, McElrath, M. Juliana, Fife, Kenneth, Were, Edwin, Tumwesigye, Elioda, Katabira, Elly, Ronald, Allan, Bukusi, Elizabeth, Cohen, Craig, Wangisi, Jonathan, Campbell, James, Tappero, Jordan, Kiarie, James, Farquhar, Carey, John-Stewart, Grace, Mugo, Nelly Rwamba
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402339/
https://ncbi.nlm.nih.gov/pubmed/25587020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu677
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados